{"name":"Edward Lain, MD","slug":"edward-lain-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amzeeq 4% Topical Foam","genericName":"Amzeeq 4% Topical Foam","slug":"amzeeq-4-topical-foam","indication":"Acne vulgaris","status":"marketed"}]}],"pipeline":[{"name":"Amzeeq 4% Topical Foam","genericName":"Amzeeq 4% Topical Foam","slug":"amzeeq-4-topical-foam","phase":"marketed","mechanism":"Amzeeq is a topical foam formulation of minocycline that reduces inflammation and bacterial colonization in acne by inhibiting bacterial protein synthesis and suppressing inflammatory mediators.","indications":["Acne vulgaris"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNYS03TzVjdDZ4N2syVUNHU1dRcnZNTGh1ZFpxYzViMUFLMzdLX2NEX0lzZ3Byb3R1LUZ0TzZ5N2R2UlEySEt3OEpCZV92T3hza3gwdFFlekRFbVBaeGJveFFmR2ZTTm93VGdxeWxpNXE3V25VQlhYS253V01HY2hQSFAwdnpMRHZOd0w2Q0R3U0xJYVVlSTNpM1JvZkgyUDhmVE53NEh2LVJzaUctQUZF?oc=5","date":"2023-03-10","type":"pipeline","source":"Dermatology Times","summary":"TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists - Dermatology Times","headline":"TMB-001 for Congenital Ichthyosis Subtypes Tested by Dermatologists","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}